We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Twenty Pneumococcal Serotyping Methods Evaluated

By LabMedica International staff writers
Posted on 30 Nov 2015
Print article
Image: Scanning electron micrograph of Streptococcus pneumoniae (Photo courtesy of the University of Manchester).
Image: Scanning electron micrograph of Streptococcus pneumoniae (Photo courtesy of the University of Manchester).
A pneumococcal serotyping method suitable for use in carriage studies should have high sensitivity, including the ability to detect multiple serotypes, detect most or all serotypes, be suitable to scale up for large projects, and be practical for resource-poor countries.

About 800,000 young children, mostly living in low-income countries, die annually from pneumococcal diseases and vaccine development requires accurate carriage studies with high sensitivity and the ability to detect multiple serotypes in individual samples. Pneumococcal disease is caused by the Streptococcus pneumoniae bacterium.

A team of scientists led by those at the Murdoch Childrens Research Institute (Parkville, Australia) established the PneuCarriage project, a large, international multicenter study dedicated to the identification of the best pneumococcal serotyping methods for carriage studies. The team distributed reference sample sets to 15 research groups for blinded testing. Twenty pneumococcal serotyping methods were used to test 81 laboratory-prepared spiked) samples. The five top-performing methods were used to test 260 nasopharyngeal field samples collected from children in six high-burden countries. Sensitivity and positive predictive value (PPV) were determined for the test methods and the reference method which is traditional serotyping of more than 100 colonies from each sample.

Fifteen methods detected the major serotype in the spiked samples with equal to or greater than 70% sensitivity, but only eight detected minor serotypes at the same threshold. For the field samples, a culture microarray method had the best overall performance (95.8% sensitivity and 93.9% PPV), while a more affordable culture and latex sweep method that has been used in low-income settings showed promising performance (79.8% sensitivity and 91.4% PPV). The 260 field samples contained 307 serotypeable pneumococci. Forty-nine of the known 97 serotypes, including 12 of the pneumococcal conjugate vaccine 13 (PCV13) types, were identified at least once. PCV7, PCV10, and PCV13 types represented 27.1%, 29.0%, and 45.6% of the 307 serotypeable pneumococci, respectively. Serotypes 19F, 23F, 6A, 15B/C, 19A, 14, 16F, 6C, 11A, 13, and 6B were the most common and together accounted for 68% of the total.

The authors concluded that that although most of the recently developed serotyping methods detected the dominant serotype in a sample, many failed to detect minor serotypes. Moreover, the performance of similar methods varied markedly, and methods optimized for testing pure isolates did not necessarily work well when testing more complex samples. These findings identified microarray with a culture amplification step as the top-performing method, but, importantly, this study did not test all the available serotyping methods. The study was published on November 17, 2015, in the journal Public Library of Science Medicine.

Related Links:

Murdoch Childrens Research Institute 


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
New
Gold Member
LEISHMANIA Test
LEISHMANIA ELISA
New
3-Position Stirrer
ST-200 and SHP-200 Series
New
DNA Extraction Kit
Ron’s Gel Extraction Mini Kit

Print article

Channels

Molecular Diagnostics

view channel
Image: A coronal MRI section shows a high-intensity focused ultrasound lesion in the left thalamus of the brain (Photo courtesy of UT Southwestern Medical Center)

Newly Identified Stroke Biomarkers Pave Way for Blood Tests to Quickly Diagnose Brain Injuries

Each year, nearly 800,000 individuals in the U.S. experience a stroke, which occurs when blood flow to specific areas of the brain is insufficient, causing brain cells to die due to a lack of oxygen.... Read more

Immunology

view channel
Image: The discovery of biomarkers could improve endometrial cancer treatment (Photo courtesy of Mount Sinai)

Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer

Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read more

Pathology

view channel
Image: As tumor cells flow through these microfluidic chambers, they are subjected to increasing shear stress and sorted based on their adhesion strength (Photo courtesy of UC San Diego)

Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread

Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.